Zydus gets USFDA final approval for Imatinib Mesylate Tablets Medical Dialogues Bureau9 April 2020 1:01 PM ISTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Imatinib Mesylate Tablets, 100 mg and 400 mg. (US RLD: Gleevec®...
Zydus gets USFDA final approval for Perphenazine Tablets USP Medical Dialogues Bureau8 April 2020 12:56 PM ISTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg. (US RLD: Trilafon®...
Coronavirus: Zydus Wellness launches hand sanitizer under Nycil brand to meet growing demand Medical Dialogues Bureau2 April 2020 1:00 PM ISTNycil sanitizer consists of neem and aloevera extracts that helps kill 99.9 percent germs, Zydus Wellness said
World's first drug for treatment of Non-Cirrhotic NASH approved: Zydus Medical Dialogues Bureau6 March 2020 2:26 PM ISTSaroglitazar is uniquely poised with its dual PPAR alpha and gamma properties – reducing the comorbidities (dyslipidemia, hypertriglyceridemia,...
Zydus gets DCGI nod for Phase I clinical trial of ZYBK2b to treat Rheumatoid Arthritis Medical Dialogues Bureau4 March 2020 10:34 AM ISTZYBK2 has been specifically designed to inhibit HLA-DRB1 Shared Epitope (SE) that determines the susceptibility of a person to develop rheumatoid...
Zydus, China Medical System enter licensing agreement for desidustat Medical Dialogues Bureau21 Jan 2020 3:15 PM ISTUnder the license agreement, CMS will pay Zydus an initial upfront payment, regulatory milestones, sales milestones and royalties on net sales of the...
Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol Medical Dialogues Bureau10 Oct 2019 11:34 AM ISTZydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1 Medical Dialogues Bureau10 Aug 2019 12:43 PM ISTDuring the quarter, Zydus Cadila entered into a marketing alliance with SIFI, the Italian leader in the development of therapeutic solutions for...
Cadila Healthcare gets OAI letter from USFDA for Moraiya facility Medical Dialogues Bureau8 Aug 2019 10:00 AM ISTThe company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila...
Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India Medical Dialogues Bureau5 Aug 2019 10:00 AM ISTSaroglitazar Magnesium was launched in India during September 2013, under the brand name 'Lipaglyn', for the treatment of hypertriglyceridemia and...
Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US Medical Dialogues Bureau21 July 2019 10:00 AM ISTThe product is a generic version of Adderall XR capsules and will be manufactured at Nesher Pharmaceuticals' manufacturing facility at St Louis in the...
Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 9:17 AM IST"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
